News

GSK: I Foresee Only Very Modest Upside Here Even If Blenrep Gets FDA Approval
Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...
PharmTech9h
EMA Encourages Use of New Approach Methodologies to Reduce Animal Testing
EMA encourages NAMs to replace animal testing, aligning with 3Rs principles, and has published a concept paper on regulatory ...
Biologic Therapeutics Market to Hit $794.5 Billion by 2029
According to the latest study from BCC Research, "Biologic Therapeutic Drugs: Technologies and Global Markets" is projected ...
Plant Services18h
Factory fallout: Manufacturing plant closures and layoffs from Wolfspeed, ArcelorMittal, Genentech. and more
These stories show how volatility in global markets is pushing manufacturers to make painful workforce decisions.
BCC Research LLC: Biologic Therapeutics Market to Hit $794.5 Billion by 2029
"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative Vaccines" BOSTON ...